Indivior Pharmaceuticals (INDV) Capital Expenditures Growth (1y) (2025 - 2026)
Indivior Pharmaceuticals (INDV) Capital Expenditures Growth (1y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -21.54% |
| 10 | Indivior Pharmaceuticals | 5.04 Bn | 4.87 Bn | 277.00 Mn | 300.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300.00% |
| Dec 31, 2025 | 50.00% |
| Sep 30, 2025 | 185.71% |
| Jun 30, 2025 | 325.00% |
| Mar 31, 2025 | 150.00% |